Skip to Main Content

Paper Details

Genomic characterization of metastatic breast cancers.
Nature
409
2019
18 amplicons, AKT1, Cancer, ESR1, GATA3, HER2, HR, KMT2C, Metastatic triple-negative breast cancers, NCOR1, NF1, RB1, RIC8A, S10, S13, S17, TP53, advanced breast cancer, breast cancer, breast cancers, cancers, cancers1, early, early breast cancer, early breast cancers, metastatic breast cancer, metastatic breast cancers, mutational, oestrogen, oestrogen and/or progesterone receptors, patients, progesterone, triple, triple-negative breast cancers
Author NameAffiliation
Charlotte K Y NgInstitute of Pathology, University Hospital Basel
Charlotte K Y NgUniversity of Basel
Charlotte K Y NgUniversity of Bern
Salvatore PiscuoglioInstitute of Pathology, University Hospital Basel
Salvatore PiscuoglioUniversity of Basel
Daniel BirnbaumInserm, Aix-Marseille University CNRS, Institut Paoli-Calmettes
  • 1 - 6

Datasets

Release 1.2